MGMT immunoreactivity and promoter methylation status in the individual tumor subgroups of brain metastases.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
MGMT immunoreactivity and promoter methylation status were significantly associated in renal cell carcinoma (p<0.05), breast carcinoma (p<0.05) and lung carcinoma (p<0.025). A similar trend was seen in melanoma (p>0.05).
创建时间：
2013-02-21
